col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


95 Results       Page 1

 [1] 
Elsevier: Respiratory Investigation
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 Autopsy case: Pathological complete response in an advanced lung cancer patient with severe immune related adverse events and COVID-19 Ryoma Moriya, Naoki Kamihata, Yoshikazu Niwa, Hisashi Kako, Hideaki Takahashi, Yutaro Kimura, et al. (+4)
2 [GO] 2024―Mar―15 Structural and organizational determinants of the capacity for COVID-19 testing and diagnoses in children: Insights from the 2009 influenza and COVID-19 pandemics Yusuke Okubo, Kazuhiro Uda
3 [GO] 2024―Mar―07 Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Tomoki Ito
4 [GO] 2024―Mar―01 Krebs von den Lungen-6 levels at admission predicts exercise-induced hypoxemia before and after discharge in patients with COVID-19 Keisuke Morikawa, Kazuyuki Tabira, Hiroyuki Takemura, Shogo Inaba, Yuta Suzuki, Osamu Hataji
5 [GO] 2024―Feb―28 Spontaneous regression of acute fibrinous organizing pneumonia induced by COVID-19 vaccination: A case report Sanshiro Haga, Ryota Otoshi, Akimasa Sekine, Taichi Kaneko, Chieri Yamada, Tomohisa Baba, et al. (+4)
6 [GO] 2024―Jan―28 Platypnoea-orthodeoxia syndrome in COVID-19 pneumonia patients: An observational study Masatoshi Hanada, Yuji Ishimatsu, Noriho Sakamoto, Nobuyuki Ashizawa, Hirotomo Yamanashi, Motohiro Sekino, et al. (+7)
7 [GO] 2024―Jan―23 Relevant factors associated with the development of chronic cough after recovery from COVID-19 Yoshihiro Kanemitsu, Kensuke Fukumitsu, Akio Niimi
8 [GO] 2024―Jan―21 Nursing and healthcare-associated pneumonia due to SARS-CoV-2 Omicron variant Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Tomoki Ito
9 [GO] 2024―Jan―10 Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia Abhishek Singla, Nusrat Harun, Daniel F. Dilling, Karim Merchant, Susan McMahan, Rebecca Ingledue, et al. (+5)
10 [GO] 2024―Jan―06 Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings? Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Tomoki Ito
11 [GO] 2023―Dec―19 Clinical features of pneumothorax associated with COVID-19: A retrospective analysis of two centres Kohei Fujita, Toshiyuki Iwata, Osamu Kanai, Hiroaki Hata, Hiroyuki Tanaka, Takuma Imakita, et al. (+5)
12 [GO] 2023―Nov―28 Reduction of mycophenolate mofetil dosage to limit prolonged viral shedding in solid organ transplant recipients with COVID-19: Two case reports Yushi Murai, Seiichiro Sakao, Fujihiro Kure, Takeshi Kawasaki, Michihiro Maruyama, Hidemi Suzuki, et al. (+2)
13 [GO] 2023―Nov―10 Delayed iliopsoas abscess following COVID-19 pneumonia Ryuichiro Takaki, Masaru Ando, Yoshio Satonaga, Michitoshi Yabe, Takamasa Kan, Erika Omote, et al. (+5)
14 [GO] 2023―Sep―30 Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study Hideki Terai, Makoto Ishii, Ryo Takemura, Ho Namkoong, Kyoko Shimamoto, Katsunori Masaki, et al. (+143)
15 [GO] 2023―Sep―27 Have clinical studies on COVID-19 matured? Isao Ito
16 [GO] 2023―Sep―15 Limited efficacy of low-dose dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective study Satoshi Inoue, Yuki Kata, Yoshihiro Suido, Kentaro Nakashima, Yukiko Otsu, Hirokazu Takayasu, et al. (+2)
17 [GO] 2023―Sep―12 Keigai-rengyo-to as post-exposure prophylaxis for severe acute respiratory syndrome coronavirus 2 infection Satoru Chiba, Kaoru Shinohara
18 [GO] 2023―Jun―20 COVID-19 and interstitial lung diseases: a multifaceted look at the relationship between the two diseases Jun Fukihara, Yasuhiro Kondoh
19 [GO] 2023―Apr―28 Hospitalized patients with X-linked disease and infected with SARS-CoV-2 in Brazil: a serial case report from the first two years of the pandemic Matheus Negri Boschiero, Nathália Mariana Santos Sansone, Fernando Augusto Lima Marson
20 [GO] 2023―Apr―22 Assessment of Changes in the Epidemiology and Prognosis of Non-SARS-CoV-2 Respiratory Infections One Year After Recovery From COVID-19 Ahmad Z. Al Meslamani, Nour Sammani
21 [GO] 2023―Apr―19 Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19 Takuya Ozawa, Takanori Asakura, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ko Lee, et al. (+30)
22 [GO] 2023―Apr―18 Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: a single-center retrospective cohort study during 5th wave in Japan Yasutaka Hirasawa, Jiro Terada, Yu Shionoya, Atsushi Fujikawa, Yuri Isaka, Yuichiro Takeshita, et al. (+7)
23 [GO] 2023―Mar―13 Reintubation in COVID-19 patients: a multicenter observational study in Japan (J-RECOVER study) Maki Miwa, Mikio Nakajima, Richard H. Kaszynski, Hideaki Goto, Atsushi Hirayama, Takashi Tagami, et al. (+5)
24 [GO] 2023―Mar―07 Reply to Letter to the Editor “Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment” Daisuke Narita, Risa Ebina-Shibuya
25 [GO] 2023―Mar―01 Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
26 [GO] 2023―Feb―02 COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: an analysis in the first specialized hospital for COVID-19 in Japan Masanori Kobayashi, Atsushi Miyamoto, Tetsuya Watanabe, Kenji Sawa, Kanako Sato, Kazuhiro Yamada, et al. (+8)
27 [GO] 2023―Feb―01 COVID-19 symptom-onset to diagnosis and diagnosis to treatment intervals are significant predictors of disease progression and hospitalization in high-risk patients: A real world analysis Hideyasu Shimizu, Jin Kawase, Masamichi Hayashi, Kazuyoshi Imaizumi, Yuji Ito, Mitsushi Okazawa
28 [GO] 2023―Jan―31 Longitudinal changes in mental health outcomes after COVID-19 hospitalization: a prospective study Chigusa Shirakawa, Ryo Tachikawa, Ryohei Yamamoto, Chisato Miyakoshi, Kentaro Iwata, Kei Endo, et al. (+9)
29 [GO] 2023―Jan―12 IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting Yasuhito Sekimoto, Mitsuaki Sekiya, Shuko Nojiri, Eri Hayakawa, Yoshihiro Masui, Manabu Tajima, et al. (+3)
30 [GO] 2022―Dec―15 Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment Daisuke Narita, Risa Ebina-Shibuya, Eisaku Miyauchi, Yoko Tsukita, Ryota Saito, Koji Murakami, et al. (+2)
31 [GO] 2022―Nov―16 SFTPB (rs11130866) and NR3C1 (rs41423247) gene variants as potential clinical biomarkers for personalized treatment strategy selection in patients with severe COVID-19 pneumonia Liliia Fishchuk, Zoia Rossokha, Valeriy Pokhylko, Yuliia Cherniavska, Olena Popova, Viktoriia Vershyhora, et al. (+2)
32 [GO] 2022―Sep―12 Clinical Practice of High-Flow Nasal Cannula Therapy in COVID-19 Pandemic Era: A Cross-Sectional Survey of Respiratory Physicians Takafumi Koyauchi, Yuzo Suzuki, Yusuke Inoue, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, et al. (+4)
33 [GO] 2022―Sep―09 Atypical pneumonia due to SARS-CoV-2: clinical differentiation using the JRS pneumonia guidelines Naoyuki Miyashita
34 [GO] 2022―Aug―22 Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facility Noriaki Ito, Yoshihiro Kitahara, Kei Miwata, Mafumi Okimoto, Toshiro Takafuta
35 [GO] 2022―Aug―08 Applicability of lung ultrasound in the assessment of COVID-19 pneumonia: Diagnostic accuracy and clinical correlations Ciurba Emilia Bianca, Sárközi Katalin Hédi, Szabó Adorjan István, Grigorescu Liana Bianca, Csipor-Fodor Alpar, Toma Tudor, Jimborean Gabriela
36 [GO] 2022―Jul―19 An increasing rate of pneumomediastinum in non-intubated COVID-19 patients: the role of steroids and a possible radiological predictor Leonardo Guidi, Alessandro Belletti, Diego Palumbo, Francesco De Cobelli, Michele De Bonis, Alberto Zangrillo
37 [GO] 2022―Jul―12 Serum gasdermin D levels are associated with the chest computed tomography findings and severity of COVID-19 Shotaro Suzuki, Mitsuru Imamura, Mariko Mouri, Tomoya Tsuchida, Hayato Tomita, Shin Matsuoka, et al. (+15)
38 [GO] 2022―Jul―11 Patient-centered outcomes at hospital discharge in mechanically ventilated COVID-19 patients in Kobe, Japan: A single-center retrospective cohort study Jiro Ito, Daisuke Kawakami, Ryutaro Seo, Kentaro Iwata, Kenjiro Ouchi, Suguru Nonami, et al. (+10)
39 [GO] 2022―May―23 Impact of Coronavirus Disease 2019 on Respiratory Care in Japan: A Nationwide Survey by the Japanese Respiratory Society Mayuka Yamane, Akihito Yokoyama
40 [GO] 2022―May―08 Clinical significance of chest CT for the exclusion of COVID-19 in pre-admission screening: is it worthwhile using chest CT with reverse-transcription polymerase chain reaction test? Kazuhiko Morikawa, Shigeki Misumi, Takao Igarashi, Ayako Fujimori, Akira Ogihara, Ryo Akao, et al. (+5)
41 [GO] 2022―Apr―25 Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution Takashi Ichiyama, Masamichi Komatsu, Yosuke Wada, Masayuki Hanaoka
42 [GO] 2022―Apr―06 Non-invasive ventilation using a novel ventilator and non-vented full-face mask for patients with respiratory failure during the COVID-19 pandemic: Report of three cases Takuma Minami, Shinichi Kai, Tomoharu Tanaka, Isao Ito, Genta Kato, Miki Nagao, et al. (+4)
43 [GO] 2022―Apr―04 The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy Nobuhiro Asai, Hideo Kato, Hiroshige Mikamo
44 [GO] 2022―Mar―31 Comparison of clinical characteristics and outcomes of COVID-19 patients undergoing early versus late intubation from initial hospital admission: A systematic review and meta-analysis Woon Hean Chong, Biplab K. Saha, Dermot J. Murphy, Amit Chopra
45 [GO] 2022―Mar―29 Respiratory rate index utility in high-flow nasal cannula oxygen therapy in COVID-19 pneumonia; what are the perfect boundaries? Mariano Mazza, Domenica Di Costanzo, Antonio M. Esquinas
46 [GO] 2022―Mar―07 Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: a propensity score-matched retrospective cohort study Takuya Tanimoto, Shinpei Tada, Suguru Fujita, Tetsu Hirakawa, Mirai Matsumura, Shoko Isoyama, et al. (+10)
47 [GO] 2022―Jan―04 Evaluation of thorax computed tomographic findings in COVID-19 variant cases F. Dilek Gökharman, Günay Tuncer Ertem, Sonay Aydın, Ayşe Büyükdemirci, Esra Yüksekkaya, Oğuzhan Tokur, Pınar N. Koşar
48 [GO] 2021―Dec―07 Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy Sumito Inoue, Akira Igarashi, Keita Morikane, Osamu Hachiya, Masafumi Watanabe, Seiji Kakehata, et al. (+2)
49 [GO] 2021―Dec―03 Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan Makoto Hibino, Shigehiro Watanabe, Shunichi Tobe, Kazunari Maeda, Shigeto Horiuchi, Sho Nishiguchi, et al. (+4)
50 [GO] 2021―Nov―26 Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections Chie Morita, Manabu Suzuki, Shinyu Izumi, Akinari Tsukada, Yoshie Tsujimoto, Keita Sakamoto, et al. (+4)
51 [GO] 2021―Nov―03 Successive disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 pandemic Satoko Sunagawa, Yoshikazu Iha, Takeshi Kinjo, Katsunori Nakamura, Jiro Fujita
52 [GO] 2021―Oct―30 High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: a retrospective cohort study confirming the utility of respiratory rate index Yuichiro Takeshita, Jiro Terada, Yasutaka Hirasawa, Taku Kinoshita, Hiroshi Tajima, Ken Koshikawa, et al. (+5)
53 [GO] 2021―Oct―12 Transient leukocytopenia following combination therapy for COVID-19 Kazuo Tsuchiya, Tomoyuki Fujisawa, Yasutaka Mochizuka, Sho Takuma, Kyohei Oishi, Yoshinari Endo, et al. (+14)
54 [GO] 2021―Oct―08 Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: a nationwide survey by the Japanese Respiratory Society Takahiro Takazono, Hiroshi Mukae, Koichi Izumikawa, Hiroshi Kakeya, Tadashi Ishida, Naoki Hasegawa, Akihito Yokoyama
55 [GO] 2021―Sep―11 Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan Yutaka Muto, Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kohei Takada, et al. (+4)
56 [GO] 2021―Sep―10 Clinical Characteristics of COVID-19 in Osaka, Japan: Comparison of the First-Third Waves with the Fourth Wave Yu Kurahara, Takehiko Kobayashi, Sayoko Shintani, Yoshinobu Matsuda, Akihiro Tamiya, Reiko Sugawara, et al. (+5)
57 [GO] 2021―Aug―17 A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO Woon Hean Chong, Biplab K. Saha, Boris I. Medarov
58 [GO] 2021―Aug―10 Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19 Takehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, Mari Tone, Keita Sakamoto, Kohei Takada, et al. (+6)
59 [GO] 2021―Jul―31 The effect of the outbreak of COVID-19 on respiratory physicians and healthcare in Japan: Serial nationwide surveys by the Japanese Respiratory Society Keisuke Kamada, Satoshi Konno, Takeshi Kaneko, Koichi Fukunaga, Yoshinori Hasegawa, Akihito Yokoyama
60 [GO] 2021―Jul―15 The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society Hiroyuki Nagase, Yoshihiro Nishimura, Hisako Matsumoto, Naoya Sugimoto, Takashi Iwanaga, Akiko Sano, et al. (+5)
61 [GO] 2021―Jul―06 The effect of driving pressures in COVID-19 ARDS: Lower may still be better as in classic ARDS Süleyman Yildirim, Burcu Acar Cinleti, Saba Mukaddes Saygili, Emre Senel, Ozlem Ediboglu, Cenk Kirakli
62 [GO] 2021―Jul―06 The impact of the COVID-19 pandemic on asthma treatment in Japan: Perspectives based on doctors' views Haruna Kitazawa, Nobuyuki Hizawa, Yoshihiro Nishimura, Takao Fujisawa, Takashi Iwanaga, Akiko Sano, et al. (+5)
63 [GO] 2021―Jun―30 COVID-19and Acute Exacerbation of Interstitial Lung Disease Yasuhiro Kondoh, Kensuke Kataoka, Masaru Ando, Yukikazu Awaya, Kazuya Ichikado, Mikio Kataoka, et al. (+8)
64 [GO] 2021―Jun―29 Computed tomography at every step: Long coronavirus disease Sonay Aydin, Edhem Unver, Erdal Karavas, Seven Yalcin, Mecit Kantarci
65 [GO] 2021―Jun―19 Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan Takehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, Mari Tone, Keita Sakamoto, Kohei Takada, et al. (+6)
66 [GO] 2021―Jun―17 Increase in humidifier lung cases owing to coronavirus disease 2019 Masafumi Shimoda, Kozo Morimoto, Yoshiaki Tanaka, Hiroyuki Kokutou, Takashi Uchiyama, Kozo Yoshimori, Ken Ohta
67 [GO] 2021―Jun―12 Increased usage of the high flow nasal cannula in COVID-19 cases in Japan -From the online questionnaire survey by the Japanese Respiratory Society- Keisuke Tomii, Jiro Terada, Kazuo Chin
68 [GO] 2021―Jun―12 Steroid Resistance and Rebound Phenomena in Patients with COVID-19 Ryosuke Imai, Shosei Ro, Yutaka Tomishima, Naoki Nishimura
69 [GO] 2021―Jun―08 Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms Maki Miwa, Mikio Nakajima, Richard H. Kaszynski, Shoichiro Hamada, Hitoshi Ando, Tomotsugu Nakano, et al. (+2)
70 [GO] 2021―Jun―01 Risk factors for transfer from respiratory intermediate CARE unit to INTENSIVE CARE unit in COVID-19 Enrico Buonamico, Vitaliano Nicola Quaranta, Esterina Boniello, Michela Dimitri, Valentina Di Lecce, Luciana Labate, et al. (+4)
71 [GO] 2021―May―28 Incidence of pneumomediastinum in COVID-19: a single-center comparison between 1st and 2nd wave Federico Tacconi, Paola Rogliani, Francesca Leonardis, Loredana Sarmati, Eleonora Fabbi, Gerardo De Carolis, et al. (+3)
72 [GO] 2021―Apr―27 Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019 Takafumi Yamaya, Eri Hagiwara, Tomohisa Baba, Takaaki Kitayama, Kota Murohashi, Katsuyuki Higa, et al. (+14)
73 [GO] 2021―Apr―06 Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic Yoko Shibata, Shigeo Muro, Akihito Yokoyama, Shu Hashimoto
74 [GO] 2021―Mar―29 Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area Yosuke Amano, Hidenori Kage, Goh Tanaka, Wataru Gonoi, Yudai Nakai, Ryo Kurokawa, et al. (+8)
75 [GO] 2021―Mar―27 Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan Takashi Katsuno, Manabu Suzuki, Masayuki Hojo, Junko Terada, Keiji Nakamura, Tetsuya Suzuki, et al. (+2)
76 [GO] 2021―Mar―20 Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients Ioannis Bellos, Kyriaki Tavernaraki, Konstantinos Stefanidis, Olympia Michalopoulou, Giota Lourida, Eleni Korompoki, et al. (+4)
77 [GO] 2021―Jan―28 The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia Takahiro Fukushima, Hiroki Kabata, Ryo Yamamoto, Tomohiro Suhara, Yoshifumi Uwamino, Yasushi Kondo, et al. (+10)
78 [GO] 2021―Jan―26 Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: the Tokyo Women’s Medical University model Ken Arimura, Etsuko Tagaya, Ken Kikuchi, Toshihiro Mitsuda, Gaku Yasuda, Haruna Azuma, et al. (+14)
79 [GO] 2021―Jan―22 Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid Hiroshi Takumida, Shinyu Izumi, Keita Sakamoto, Masao Hashimoto, Satoru Ishii, Manabu Suzuki, et al. (+4)
80 [GO] 2021―Jan―01 Characteristics of COVID-19 patients admitted into two hospitals in Sapporo, Japan: Analyses and insights from two outbreak waves Takeshi Hattori, Atsushi Saito, Hirofumi Chiba, Koji Kuronuma, Masaru Amishima, Daisuke Morinaga, et al. (+3)
81 [GO] 2020―Dec―18 Our future: Experiencing the coronavirus disease 2019 (COVID-19) outbreak and pandemic Shu Hashimoto, Mari Hikichi, Shuichiro Maruoka, Yasuhiro Gon
82 [GO] 2020―Dec―03 Mycoplasma pneumoniae pneumonia and respiratory syncytial virus infection in Japan during the severe acute respiratory syndrome coronavirus 2 pandemic Jiro Fujita
83 [GO] 2020―Nov―30 Persistent Hiccup: A Rare Presentation of COVID-19 Nader Bakheet, Rabab Fouad, Abdel Meguid Kassem, Wessam Hussin, Mostafa El-Shazly
84 [GO] 2020―Nov―23 Decrease in Hemoglobin Level Predicts Increased Risk for Severe Respiratory Failure in COVID-19 Patients with Pneumonia Moriyasu Anai, Kimitaka Akaike, Hajime Iwagoe, Takefumi Akasaka, Takushi Higuchi, Aoi Miyazaki, et al. (+12)
85 [GO] 2020―Nov―16 Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic Satoko Sunagawa, Yoshikazu Iha, Takeshi Kinjo, Katsunori Nakamura, Jiro Fujita
86 [GO] 2020―Oct―07 Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series Hideta Nakamura, Kazuya Miyagi, Mariko Otsuki, Yuuri Higure, Naoya Nishiyama, Takeshi Kinjo, et al. (+4)
87 [GO] 2020―Oct―05 SARS-CoV-2 as a causative agent of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disorders Jiro Fujita
88 [GO] 2020―Sep―19 Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic J. Guiot, M. Henket, A.N. Frix, M. Delvaux, A. Denis, L. Giltay, et al. (+26)
89 [GO] 2020―Sep―18 COVID-19 pandemic and the incidence of community-acquired pneumonia in elderly people Takashi Yamamoto, Kosaku Komiya, Naoko Fujita, Eiji Okabe, Kazufumi Hiramatsu, Jun-ichi Kadota
90 [GO] 2020―Aug―28 Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases Kota Murohashi, Eri Hagiwara, Takaaki Kitayama, Takafumi Yamaya, Katsuyuki Higa, Yozo Sato, et al. (+15)
91 [GO] 2020―Aug―21 Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019 Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kohei Takada, Yutaka Muto, et al. (+5)
92 [GO] 2020―Jun―28 Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020 Toshie Manabe, Hiroyasu Akatsu, Kazuhiko Kotani, Koichiro Kudo
93 [GO] 2020―Jun―26 COVID-19: Role of neutrophil extracellular traps in acute lung injury Ahmed Yaqinuddin, Peter Kvietys, Junaid Kashir
94 [GO] 2020―Apr―17 COVID-19 outbreak: an elusive enemy Toshiaki Kikuchi
95 [GO] 2020―Feb―21 Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells Mutsuo Yamaya, Hidekazu Nishimura, Xue Deng, Mitsuru Sugawara, Oshi Watanabe, Kazuhiro Nomura, et al. (+4)
 [1] 

95 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec